Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Details for Australian Patent Application No. 2012202089 (hide)

Owner Gilead Sciences, Inc.

Inventors Montgomery, Alan Bruce; Keller, Manfred; Lintz, Fran-Chrisophe

Agent Spruson & Ferguson

Pub. Number AU-A-2012202089

Parent 2009233632

Filing date 11 April 2012

Wipo publication date 3 May 2012

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61L 9/04 (2006.01) Disinfection, sterilisation or deodorisation of air - using substances evaporated in the air without heating

Event Publications

26 April 2012 Complete Application Filed

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202089

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202090-Automated staining system and reaction chamber

2012202088-Non-protein stabilized clostridial toxin pharmaceutical compositions